[go: up one dir, main page]

TR200101141T2 - Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim - Google Patents

Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim

Info

Publication number
TR200101141T2
TR200101141T2 TR2001/01141T TR200101141T TR200101141T2 TR 200101141 T2 TR200101141 T2 TR 200101141T2 TR 2001/01141 T TR2001/01141 T TR 2001/01141T TR 200101141 T TR200101141 T TR 200101141T TR 200101141 T2 TR200101141 T2 TR 200101141T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
composition containing
dna encoding
antitumor effect
antigenic protein
Prior art date
Application number
TR2001/01141T
Other languages
English (en)
Inventor
Parente Dino
Maria Di Massimo Anna
De Santis Rita
Original Assignee
Menarini Ricerche S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche S.P.A. filed Critical Menarini Ricerche S.P.A.
Publication of TR200101141T2 publication Critical patent/TR200101141T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Isbu metinde, bir antitümör Ag-spesifik immün yaniti indüklemek amaciyla uygun eksipiyan ve ilave maddelerle birlikte, tümör hücrelerinde asiri eksprese olan bir proteine mahsus parçalari sifreleyen bir veya daha fazla DNA molekülünü ihtiva eden farmasötik bir bilesim sunulmaktadir.
TR2001/01141T 1998-10-30 1999-10-18 Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim TR200101141T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002330A IT1303683B1 (it) 1998-10-30 1998-10-30 Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica.

Publications (1)

Publication Number Publication Date
TR200101141T2 true TR200101141T2 (tr) 2001-09-21

Family

ID=11380969

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01141T TR200101141T2 (tr) 1998-10-30 1999-10-18 Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim

Country Status (19)

Country Link
EP (1) EP1124956A2 (tr)
JP (1) JP2002528519A (tr)
CN (1) CN1324406A (tr)
AR (1) AR020927A1 (tr)
AU (1) AU1152200A (tr)
BG (1) BG105458A (tr)
BR (1) BR9914892A (tr)
CA (1) CA2348745A1 (tr)
CO (1) CO5231134A1 (tr)
CZ (1) CZ20011521A3 (tr)
EA (1) EA200100395A1 (tr)
HU (1) HUP0103784A2 (tr)
IT (1) IT1303683B1 (tr)
MX (1) MXPA01004186A (tr)
PE (1) PE20001287A1 (tr)
PL (1) PL348156A1 (tr)
SK (1) SK5712001A3 (tr)
TR (1) TR200101141T2 (tr)
WO (1) WO2000025827A2 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
EP1257565A4 (en) * 2000-02-01 2005-04-06 Austin Research Inst DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY
DE60140461D1 (de) * 2000-09-11 2009-12-24 Genzyme Corp Muc1 extrazelluläre domäne und zusammensetzungen für krebsbehandlung, und davon abgeleitete verfahren
AU2002246791C1 (en) 2000-12-22 2008-04-03 Dana-Farber Cancer Institute, Inc. Regulation of cell growth by MUC1
MXPA05010255A (es) * 2003-03-24 2005-12-14 Scripps Research Inst Vacunas de adn contra crecimiento tumoral y metodos de uso de las mismas.
US7696306B2 (en) 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
WO2005042573A1 (en) * 2003-10-24 2005-05-12 Dana-Farber Cancer Institute, Inc. Modulation of the interaction of muc1 with muc1 ligands
US7871784B2 (en) 2007-02-02 2011-01-18 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins
US7972870B2 (en) 2007-02-02 2011-07-05 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
CN106279435B (zh) * 2016-08-16 2019-06-07 新乡医学院 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用
CN114230656B (zh) * 2021-03-24 2025-02-25 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽组合及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262545B (it) * 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A Sistema di espressione per linee cellulari eucariotiche
WO1998037095A2 (en) * 1997-02-24 1998-08-27 Therion Biologics Corporation Recombinant pox virus for immunization against muc1 tumor-associated antigen

Also Published As

Publication number Publication date
BR9914892A (pt) 2001-07-17
PL348156A1 (en) 2002-05-06
AR020927A1 (es) 2002-06-05
AU1152200A (en) 2000-05-22
HUP0103784A2 (hu) 2002-02-28
EP1124956A2 (en) 2001-08-22
CA2348745A1 (en) 2000-05-11
WO2000025827A2 (en) 2000-05-11
WO2000025827A3 (en) 2000-08-10
IT1303683B1 (it) 2001-02-23
CN1324406A (zh) 2001-11-28
SK5712001A3 (en) 2002-04-04
CZ20011521A3 (cs) 2001-10-17
EA200100395A1 (ru) 2001-10-22
JP2002528519A (ja) 2002-09-03
ITMI982330A0 (it) 1998-10-30
BG105458A (en) 2002-06-28
CO5231134A1 (es) 2002-12-27
MXPA01004186A (es) 2002-06-04
PE20001287A1 (es) 2000-12-07
ITMI982330A1 (it) 2000-04-30

Similar Documents

Publication Publication Date Title
TR199901571T2 (tr) Tüberkülozun immünoterapi teshisi için bilesikler ve yöntemler.
NO20014415L (no) Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
TR200101141T2 (tr) Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
BR0214840A (pt) Genes
DE60026563D1 (de) Herstellung von polyketiden
CY1113064T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 184ρ1ε2 χρησιμα στη θεραπεια και ανιχνευση καρκινου
ATE273388T1 (de) Veränderte menschliche c3-proteine
DK1255845T3 (da) Modificerede cytokiner til anvendelse i cancerterapi
DE60118359D1 (de) Humanische pellino-polypeptide
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
DE69033810D1 (de) Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
ATE316136T1 (de) Nierenpolycystose-gen
ATE381351T1 (de) Anwendung des herpes simplex virus glykoproteins- d zur unterdrückung von immunantworten
PT938329E (pt) Composicao de tlp imunogenica
DE69733491D1 (de) In Krebszellen überexprimiertes Genprodukt
NO20020329D0 (no) Antitumor antistoffer, proteiner og anvendelser derav
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
CY1112424T1 (el) Πυρηνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 238ρ1β2 χρησιμα στην αγωγη και ανιχνευση του καρκινου
DE69736325D1 (de) Cr1 fragmente und deren verwendung
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse